Protego Biopharma, Inc. · CIK 1796909
Protego Biopharma, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Dec 3, 2025
through Dec 3, 2025
through Dec 3, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $130,442,180
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $32,942,190
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (1)
-
0001231919-25-000568D · Dec 3, 2025 · Other Health CareOffering: $130,442,180Sold: $32,942,190